Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 842824, 8 pages
http://dx.doi.org/10.1155/2013/842824
Research Article

Meta-Analysis of the Clinical Value of Danshen Injection and Huangqi Injection in Liver Cirrhosis

1Department of Radiation Oncology, Changzhou Tumor Hospital Soochow University, Changzhou 213000, China
2Department of Laboratory Medicine, Changzhou Tumor Hospital Soochow University, Changzhou 213000, China
3Department of Cardiothoracic Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
4Department of Oncology, Changzhou Tumor Hospital Soochow University, Changzhou 213000, China
5Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Received 20 May 2013; Accepted 24 July 2013

Academic Editor: Qing He

Copyright © 2013 Changtai Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Dai and H. C. Jiang, “Advances in gene therapy of liver cirrhosis: a review,” World Journal of Gastroenterology, vol. 7, no. 1, pp. 1–8, 2001. View at Google Scholar · View at Scopus
  2. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Liu and D. Fan, “Hepatitis B in China,” The Lancet, vol. 369, no. 9573, pp. 1582–1583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Custer, S. D. Sullivan, T. K. Hazlet, U. Iloeje, D. L. Veenstra, and K. V. Kowdley, “Global epidemiology of hepatitis B virus,” Journal of Clinical Gastroenterology, vol. 38, no. 10, supplement 3, pp. S158–S168, 2004. View at Google Scholar · View at Scopus
  5. Q. Shen, Q. W. Sun, Z. Zhang et al., “The treatment for 39 cases of cirrhosis with compound Danshen injection and Huangqi injection,” Shang Hai Yi Yao, vol. 20, no. 4, pp. 26–28, 1999. View at Google Scholar
  6. X. Chen, X. Li, and M. Liu, “Compound Danshen Huangqi injection treatment for 80 cases of liver fibrosis,” Zhong Xi Yi Jie He Gan Bing Za Zhi, vol. 10, no. 3, p. 39, 2000. View at Google Scholar
  7. Y. J. Cai, Y. P. Gao, Q. Q. Zhang et al., “Compound Huangqi Danshen injection in the treatment for 44 cases of liver cirrhosis caused by hepatitis chronic hepatitis,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 21, no. 7, pp. 548–549, 2001. View at Google Scholar
  8. C. X. Zhou, “The treatment for 120 cases cirrhosis caused by hepatitis compound with Danshen combined with Huangqi,” Xian Dai Zhong Xi Yi Jie He Za Zhi, vol. 11, no. 21, pp. 2111–2112, 2002. View at Google Scholar
  9. Y. Q. Liu, W. Han, Z. J. Wang, L. X. Li, and S. Q. Gao, “The efficacy of Huangqi combined with Danshen injection in the treatment for liver cirrhosis,” Ji Lin Zhong Yi Yao, vol. 22, no. 5, p. 15, 2002. View at Google Scholar
  10. J. Chen, Z. Chen, X. J. Huang et al., “The effect on serum markers reflecting the liver function and liver fibrosis in the treatment for liver cirrhosis with Danshen, Huangqi injection,” An Hui Zhong Yi Xue Yuan Xue Bao, vol. 22, no. 5, pp. 32–34, 2003. View at Google Scholar
  11. Y. Cai, “The treatment with Danshen combined with Huangqi injection for 66 cases of liver cirrhosis,” Shan Xi Yi Yao Za Zhi, vol. 33, no. 4, pp. 342–343, 2004. View at Google Scholar
  12. A. M. Wu, L. M. Zhang, H. Tang et al., “Liver hemodynamics of cirrhosis resulted from hepatitis B liver of the treatment with Danshen and Huangqi injection intravenous infusion,” Shi Jie Gan Ran Za Zhi, vol. 6, no. 1, pp. 40–42, 2006. View at Google Scholar
  13. S. H. Yi and Y. F. Li, “The treatment with Huangqi injection and Danshen injection for 45 cases of cirrhosis caused by chronic hepatitis,” Zhe Jiang Zhong Yi Za Zhi, vol. 42, no. 4, p. 243, 2007. View at Google Scholar
  14. A. Pen and Z. Y. Wang, “Clinical observation on Huangqi injection and Danshen injection in the treatment for 52 cases of patients,” Zhongguo Yi Yuan Yao Xue Za Zhi, vol. 30, no. 13, pp. 1131–1133, 2010. View at Google Scholar
  15. S. J. Liu, W. J. Lin, D. J. Tu et al., “The treatment for decompensated cirrhosis due to chronic hepatitis B liver with Danshen injection, Huangqi injection combined with lamivudine,” Zhongguo Zhong Yi Ji Zhen, vol. 19, no. 6, pp. 934–935, 2010. View at Google Scholar
  16. F. Cheng, Y. Li, L. Feng, and S. Li, “Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury,” Transplantation Proceedings, vol. 40, no. 7, pp. 2167–2170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. P. Arthur, “Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C,” Gastroenterology, vol. 122, no. 5, pp. 1525–1528, 2002. View at Google Scholar · View at Scopus
  18. V. Soriano, P. Labarga, A. Ruiz-Sancho, J. Garcia-Samaniego, and P. Barreiro, “Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin,” AIDS, vol. 20, no. 17, pp. 2225–2227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Y. Pei, M. C. Zheng, and H. L. Liang, “Meta-analysis of curative effect of Danshen injection compared with puerarin on coronary heart disease,” He Nan Zhong Yi, vol. 28, no. 7, pp. 91–92, 2008. View at Google Scholar
  20. X. Q. Wang and Y. Zhang, “Shengmai injection combined with Compound Danshen injection in the treatment for 64 cases of children with acute viral myocarditis,” Zhongguo Zhong Yi Ji Zhen, vol. 20, no. 7, pp. 1184–1185, 2011. View at Google Scholar
  21. X. Yang and C. M. Du, “The Medofenoxate and Huangqi injection in the treatment for 68 cases of patients with cerebral vascular accident,” Si Chuan Zhong Yi, vol. 20, no. 1, p. 43, 2002. View at Google Scholar
  22. H. W. Lin and H. Q. Peng, “Effect of compound Danshen injection on t-PA, PAI and GMP-140 in the patients with acute myocardial infarction,” Zhongguo Zhong Yi Ji Zhen, vol. 14, no. 7, pp. 615–616, 2005. View at Google Scholar
  23. L. J. Ye, “Efficacy observation of Danshen injection combined with Shenmai injection in treating chronic hepatitis B,” Hai Xia Yao Xue, vol. 24, no. 6, pp. 181–182, 2012. View at Google Scholar
  24. Z. H. Xu, “The application of compound Danshen injection in epidemic hemorrhagic fever,” Xin Zhong Yi, vol. 15, no. 3, pp. 38–39, 1995. View at Google Scholar
  25. S. L. Yang, D. Li, and J. Y. Yan, “A large dose of compound Danshen injection in the treatment of 24 cases of patients with acute leukemia complicated with disseminated intravascular coagulation,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 20, no. 3, pp. 226–227, 2000. View at Google Scholar
  26. Y. L. Bai, “Therapeutic effect of danshen injection on chronic active hepatitis,” Zhong Xi Yi Jie He Za Zhi, vol. 4, no. 2, pp. 86–87, 1984. View at Google Scholar · View at Scopus
  27. M. He, M. L. Luo, L. J. Chen et al., “System review of Huangqi injection in the treatment for viral myocarditis,” Zhongguo Yao Fang, vol. 21, no. 48, pp. 4570–4575, 2010. View at Google Scholar
  28. S. Fu, J. Zhang, F. Menniti-Ippolito et al., “Huangqi injection (a traditional chinese patent medicine) for chronic heart failure: a systematic review,” PLoS One, vol. 6, no. 5, Article ID e19604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Chao, Y. M. Xi, and R. R. Jin, “The evaluation of clinical efficacy and safety of aplastic anemia in treatment of Huangqi injection,” Zhongguo Xun Zheng Yi Xue, vol. 11, no. 10, pp. 1205–1209, 2011. View at Google Scholar
  30. S. L. Wang and C. L. Guo, “Clinical efficacy analysis of huangqi injection in the treatment 15 cases of patients with chronic nephritis,” Ji Lin Yi Xue, vol. 33, no. 30, p. 6549, 2012. View at Google Scholar
  31. T. Sun, H. Xu, and F. Xu, “Astragalus injection for hypertensive renal damage: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 929025, 6 pages, 2012. View at Publisher · View at Google Scholar
  32. Y. W. Bai, “Clinical observation of Huangqi injection in treatment of primary nephrotic syndrome,” An Hui Yi Xue, vol. 25, no. 4, pp. 299–300, 2004. View at Google Scholar
  33. J. R. Lin and C. Deng, “Clinical study of Huangqi injection in the treatment of children with nephrotic syndrome,” Shi Zhen Guo Yi Guo Yao, vol. 18, no. 1, pp. 169–170, 2007. View at Google Scholar
  34. M. Li, W. Wang, J. Xue, Y. Gu, and S. Lin, “Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 412–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. W. Xu and C. M. Fu, “Advances in the pharmacologics of Salvia miltiorrhiza,” Yi Xue Zong Shu, vol. 12, no. 23, pp. 1467–1469, 2006. View at Google Scholar
  36. Y. Gu, W. Gu, and S. L. Yu, “Research progress on pharmacological action of Salvia miltiorrhiza,” Ren Shen Yan Jiu, vol. 19, no. 1, pp. 25–27, 2007. View at Google Scholar
  37. Y. Z. Liu, D. L. Ma, and J. Gao, “The protective effects of Huangqi injection on immunological liver injury in mice,” Tian Jin Yi Ke Da Xue Xue Bao, vol. 10, no. 2, pp. 190–191, 2004. View at Google Scholar
  38. G.-H. Chen and W.-F. Huang, “Progress in pharmacological effects of compositions of Astragalus membranaceus,” Zhongguo Xin Yao Za Zhi, vol. 17, no. 17, pp. 1482–1485, 2008. View at Google Scholar · View at Scopus
  39. Y. J. Wang, Q. Z. Quan, and S. Ziqin, “Research on the immune effect of Astragalus membranaceus on ICAM-1 expression in liver fibrosis,” Zhongguo Lin Chuang Yao Li Xue Yu Zhi, vol. 5, no. 1, pp. 49–51, 2000. View at Google Scholar
  40. Z. X. Sun, A. P. Wang, and X. Y. Dong, “Huangqi injection in the treatment of chronic hepatitis B: analysis of 60 cases,” Shan Dong Yi Xue, vol. 41, no. 2, p. 38, 2001. View at Google Scholar
  41. M. L. Wen and Y. Han, “Observation on the clinical safety of Danshen injection,” Zhongguo Fang Ji Xue Za Zhi, vol. 18, no. 22, pp. 322–324, 2012. View at Google Scholar